Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Clinical experience and review of literature

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Kwon, Steve ^a   Dong, Zhao M ^b   Wu, Peter C ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Cutaneous; Sentinel lymph node; Squamous cell carcinoma; Staging

Indexed keywords

ADULT; AGED; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECURRENT DISEASE; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; CANCER STAGING; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; SKIN TUMOR;

CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 79960560469     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-80     Document Type: Review

References (39)

1. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001, 344:975-983. 10.1056/NEJM200103293441306, 11274625.
2. Rudolph R, Zelac DE. Squamous cell carcinoma of the skin. Plast Reconstr Surg 2004, 114:82e-94e.
3. Strom SS, Yamamura Y. Epidemiology of nonmelanoma skin cancer. Clin Plast Surg 1997, 24:627-636.
4. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992, 327:1649-1662. 10.1056/NEJM199212033272307, 1435901.
5. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990. 10.1016/0190-9622(92)70144-5, 1607418.
6. North JH, Spellman JE, Driscoll D, Velez A, Kraybill WG, Petrelli NJ. Advanced cutaneous squamous cell carcinoma of the trunk and extremity: analysis of prognostic factors. J Surg Oncol 1997, 64:212-217. 10.1002/(SICI)1096-9098(199703)64:3<212::AID-JSO7>3.0.CO;2-D, 9121152.
7. Veness MJ. Time to rethink TNM staging in cutaneous SCC. Lancet Oncol 2008, 9:702-703. 10.1016/S1470-2045(08)70185-2, 18672208.
8. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008, 9:713-720. 10.1016/S1470-2045(08)70178-5, 18617440.
9. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, Ross MI, Cormier JN. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006, 13:902-909. 10.1245/ASO.2006.07.022, 16788750.
10. Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003, 29:135-140. 10.1046/j.1524-4725.2003.29035.x, 12562341.
11. Martinez JC, Cook JL. High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection?. Dermatol Surg 2007, 33:410-420. 10.1111/j.1524-4725.2007.33087.x, 17430374.
12. Garcia-Zuazaga J, Olbricht SM. Cutaneous squamous cell carcinoma. Adv Dermatol 2008, 24:33-57.
13. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999, 230:453-463. discussion 463-455, 10.1097/00000658-199910000-00001, 1420894, 10522715.
14. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ, Balch CM, Reintgen DS, Ross MI. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976-983.
15. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000, 18:2560-2566.
16. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, et al. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med 1998, 339:941-946. 10.1056/NEJM199810013391401, 9753708.
17. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307-1317. 10.1056/NEJMoa060992, 17005948.
18. van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol 2010, 7:446-454. 10.1038/nrclinonc.2010.100, 20567244.
19. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol 2006, 13:1655-1663. 10.1245/s10434-006-9066-0, 17016755.
20. Altinyollar H, Berberoglu U, Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002, 28:72-74. 10.1053/ejso.2001.1206, 11869018.
21. Michl C, Starz H, Bachter D, Balda BR. Sentinel lymphonodectomy in nonmelanoma skin malignancies. Br J Dermatol 2003, 149:763-769. 10.1046/j.1365-2133.2003.05578.x, 14616367.
22. Eastman AL, Erdman WA, Lindberg GM, Hunt JL, Purdue GF, Fleming JB. Sentinel lymph node biopsy identifies occult nodal metastases in patients with Marjolin's ulcer. J Burn Care Rehabil 2004, 25:241-245. 10.1097/01.BCR.0000124791.17426.58, 15273464.
23. Wagner JD, Evdokimow DZ, Weisberger E, Moore D, Chuang TY, Wenck S, Coleman JJ. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004, 140:75-79. 10.1001/archderm.140.1.75, 14732663.
24. Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope 2006, 112:1-15.
25. Sahn RE, Lang PG. Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers. Dermatol Surg 2007, 33:786-792. discussion 792-783, 10.1111/j.1524-4725.2007.33171.x, 17598843.
26. Renzi C, Caggiati A, Mannooranparampil TJ, Passarelli F, Tartaglione G, Pennasilico GM, Cecconi S, Potenza C, Pasquini P. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007, 33:364-369.
27. Nouri K, Rivas MP, Pedroso F, Bhatia R, Civantos F. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Arch Dermatol 2004, 140:1284.
28. Tartaglione G, Potenza C, Caggiati A, Maggiore M, Gabrielli F, Migliano E, Pagan M, Concolino F, Ruatti P. Lymphatic mapping and sentinel node identification in squamous cell carcinoma and melanoma of the head and neck. Tumori 2002, 88:S39-41.
29. Tartaglione G, Potenza C, Caggiati A, Gabrielli F, Russo A, Pagan M. Sentinel node radiolocalisation and predictive value in lip squamous cell carcinoma. Radiol Med 2003, 106:256-261.
30. Hatta N, Morita R, Yamada M, Takehara K, Ichiyanagi K, Yokoyama K. Implications of popliteal lymph node detected by sentinel lymph node biopsy. Dermatol Surg 2005, 31:327-330.
31. Yamada M, Hatta N, Sogo K, Komura K, Hamaguchi Y, Takehara K. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg 2004, 30:1424-1429. 10.1111/j.1524-4725.2004.30440.x, 15522026.
32. Stadelmann WK, Javaheri S, Cruse CW, Reintgen DS. The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg Am 1997, 22:726-731. 10.1016/S0363-5023(97)80136-0, 9260634.
33. Weisberg NK, Bertagnolli MM, Becker DS. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000, 43:483-488. 10.1067/mjd.2000.106367, 10954660.
34. Ozcelik D, Tatlidede S, Hacikerim S, Ugurlu K, Atay M. The use of sentinel lymph node biopsy in squamous cell carcinoma of the foot: a case report. J Foot Ankle Surg 2004, 43:60-63. 10.1053/j.jfas.2003.11.003, 14752766.
35. Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, Perez-Bernal AM, Camacho F. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol 2005, 141:110-111. 10.1001/archderm.141.1.110, 15655164.
36. Marks R. Squamous cell carcinoma. Lancet 1996, 347:735-738. 10.1016/S0140-6736(96)90081-1, 8602006.
37. Cook MG, Green MA, Anderson B, Eggermont AM, Ruiter DJ, Spatz A, Kissin MW, Powell BW. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003, 200:314-319. 10.1002/path.1365, 12845627.
38. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008, 9:713-720. 10.1016/S1470-2045(08)70178-5, 18617440.
39. Jensen V, Prasad AR, Smith A, Raju M, Wendel CS, Schmelz M, Leyva W, Warneke J, Krouse RS. Prognostic criteria for squamous cell cancer of the skin. J Surg Res 2010, 159:509-516. 10.1016/j.jss.2008.12.008, 19375720.